VIDEO

FindCenter AddIcon

Paul Stamets on Fungal Intelligence

By Paul Stamets — 2019

Paul Stamets is a mycologist and ambassador for the fungal kingdom. His life's work has been dedicated to studying mushrooms and their crucial role in ecosystems. In this interview he makes us question the reality of our nature and how mushrooms impact climate change, addiction, and mental health. See more...

30:44 min

01:01:21

Psychedelics: Treating Addiction, Depression and Anxiety with Dr. Roland Griffiths

Psychedelics were the subject of serious medical research in the 1940s to the 1960s, when many scientists believed some of the mind-bending compounds held tremendous therapeutic promise for treating a number of conditions including severe mental health problems and alcohol addiction.

Video
Roland Griffiths
2019
FindCenter AddIcon
01:15:24

Roland Griffiths, Ph.D. on Psilocybin, Psychedelic Therapies & Mystical Experiences

Dr. Roland R. Griffiths is a clinical pharmacologist at Johns Hopkins. Dr. Griffiths has been researching mood-altering compounds for over 40 years, has published over 360 times, and started the psilocybin research program at Johns Hopkins nearly 2 decades ago.

Video
Roland Griffiths
2017
FindCenter AddIcon
30:33

Dr. Robin Carhart-Harris - the Science of Psychedelics with Magic Mushrooms

Head of Psychedelic Research, Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, Dr. Robin Carhart-Harris share today with us his knowledge and wisdom as a scientist about the magic mushrooms.

Video
Robin Carhart-Harris
2017
FindCenter AddIcon
54:19

Robin Carhart-Harris - Psychedelic Drugs in Science and Medicine

New research using psychedelic drugs to understand the brain could lead to new treatments for mental disorders such as depression.

Video
Robin Carhart-Harris
2015
FindCenter AddIcon
27:57

How Psychedelics Can Treat Depression - Robin Carhart Harris

The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.

Video
Robin Carhart-Harris
2016
FindCenter AddIcon
17:18

Dr. Robin Carhart Harris: Psilocybin and the Psychedelic State

Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.

Video
Robin Carhart-Harris
2013
FindCenter AddIcon
16:26

Psychedelics: Lifting the Veil | Robin Carhart-Harris | TEDxWarwick

Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment.

Video
Robin Carhart-Harris
2016
FindCenter AddIcon
24:21

Amanda Feilding: The Beckley Foundation’s Program of Psychedelic Research

Psychedelics afford a unique opportunity to expand our understanding of consciousness and its altered states, to develop techniques for enhancing consciousness, and to uncover new avenues of treatment and improved therapeutic techniques.

Video
Amanda Feilding
2013
FindCenter AddIcon
01:11:17

Opening Plenary: Rick Doblin, Amanda Feilding & Beatriz Labate

Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.

Video
Rick Doblin
2017
FindCenter AddIcon
01:02:06

James Fadiman & Sophia Korb: Microdosing - the Phenomenon, Research Results & Startling Surprises

A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

Video
James Fadiman
2017
FindCenter AddIcon

EXPLORE TOPIC

Addiction